A History of Outperforming Analyst Forecasts and Beating the Odds: Amneal Pharmaceuticals Inc (AMRX)
With 2.73 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.92 million shares. The 52-week range on AMRX shows that it touched its highest point at $9.48 and its lowest point at $5.81 during that stretch. It currently has a 1-year price target of $11.67. Beta for […]
Views of Wall Street’s Leading Experts on Amneal Pharmaceuticals Inc
With 1.36 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.74 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $7.645 whereas the lowest price it dropped to was $7.5. The […]
It makes sense and dollars to buy Amneal Pharmaceuticals Inc (AMRX) stock
With 1.07 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.73 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $7.29 whereas the lowest price it dropped to was $7.021. The […]
Check out these key findings about Amneal Pharmaceuticals Inc (AMRX)
With 1.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.73 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $7.24 whereas the lowest price it dropped to was $7.105. The […]
A better buy-in window may exist right now for Amneal Pharmaceuticals Inc (AMRX)
With 2.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.67 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $7.22 whereas the lowest price it dropped to was $6.685. The […]
Does Amneal Pharmaceuticals Inc (AMRX) offer a good opportunity for investors?
With 1.46 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.55 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $8.23 whereas the lowest price it dropped to was $8.04. The […]
The growth track for Amneal Pharmaceuticals Inc (AMRX) has changed recently
With 1.19 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.47 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $8.92 whereas the lowest price it dropped to was $8.7146. The […]
There is no way Amneal Pharmaceuticals Inc (AMRX) can keep these numbers up
With 1.58 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.44 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $8.78 whereas the lowest price it dropped to was $8.62. The […]
Amneal Pharmaceuticals Inc (AMRX) Performance and Fundamentals Dashboard tells a completely different story
With 1.93 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.35 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $9.1 whereas the lowest price it dropped to was $8.775. The […]
How does Amneal Pharmaceuticals Inc (AMRX) change from a tortoise to a hare?
With 2.45 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.27 million shares. The 52-week range on AMRX shows that it touched its highest point at $9.48 and its lowest point at $5.18 during that stretch. It currently has a 1-year price target of $11.50. Beta for […]
